학술논문
Long-term Efficacy of Ozanimod by Age Category in Patients With Relapsing Multiple Sclerosis in Two Phase 3 Trials and an Open-label Extension Trial
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
14770970